ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CANF Company Profile and Key Details

AMEX : CANF

Can-Fite BioPharma Ltd.

$1.52

0.12+8.57%

At Close 4:00 PM

66.28

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CANF Stock Price Chart

Stock Price Today

Can-Fite BioPharma Ltd. (CANF) stock surged +8.57%, trading at $1.52 on AMEX, up from the previous close of $1.40. The stock opened at $1.41, fluctuating between $1.42 and $1.52 in the recent session.

Stock Snapshot

1.4

Prev. Close

1.41

Open

9.27M

Market Cap

6.1M

Number of Shares

1.415

Day Low

1.52

Day High

-0.58

P/E Ratio

27,304.3%

Free Float in %

-2.6

EPS (TTM)

1.38

Book Value

0.02

Cash Flow per Share

63.65K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	1.41	1.52	1.41	1.52	63.6K
Apr 01, 2025	1.46	1.50	1.38	1.40	124.84K
Mar 31, 2025	1.45	1.49	1.45	1.48	41.78K
Mar 28, 2025	1.50	1.56	1.44	1.48	96.45K
Mar 27, 2025	1.51	1.54	1.51	1.54	51.97K
Mar 26, 2025	1.53	1.59	1.51	1.52	81.04K
Mar 25, 2025	1.58	1.63	1.53	1.57	92.02K
Mar 24, 2025	1.74	1.74	1.55	1.62	418.59K
Mar 21, 2025	1.53	1.66	1.51	1.60	186.3K
Mar 20, 2025	1.61	1.75	1.50	1.51	374.47K
Mar 19, 2025	2.10	2.33	1.59	1.63	1.74M
Mar 18, 2025	1.90	2.21	1.67	2.02	3.5M
Mar 17, 2025	1.65	1.76	1.60	1.65	52.62K
Mar 14, 2025	1.56	1.65	1.54	1.63	35.8K
Mar 13, 2025	1.53	1.57	1.52	1.56	14.44K
Mar 12, 2025	1.51	1.58	1.51	1.55	28.7K
Mar 11, 2025	1.53	1.59	1.46	1.55	21.84K
Mar 10, 2025	1.59	1.61	1.45	1.53	53.04K
Mar 07, 2025	1.56	1.76	1.54	1.58	32.7K
Mar 06, 2025	1.62	1.63	1.52	1.60	34.06K

Contact Details

Petah Tikva, 4951778

Israel

Website: https://www.canfite.comContact: 972 392 41114

About Company

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. Can-Fite BioPharma Ltd. was incorporated in 1994 and is headquartered in Petah Tikva, Israel.

Frequently Asked Questions

What is the current Can-Fite BioPharma Ltd. (CANF) stock price?

Can-Fite BioPharma Ltd. (AMEX: CANF) stock price is $1.52 in the last trading session. During the trading session, CANF stock reached the peak price of $1.52 while $1.42 was the lowest point it dropped to. The percentage change in CANF stock occurred in the recent session was 8.57% while the dollar amount for the price change in CANF stock was $0.12.

CANF's industry and sector of operation?

The AMEX listed CANF is part of Biotechnology industry that operates in the broader Healthcare sector. Can-Fite BioPharma Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CANF?

Dr. Vibeke Strand FACP, FACR, FACR (USA), M.D.
Senior Clinical Advisor
Dr. Sari Fishman Ph.D.
Vice President of Bus. Devel.
Dr. Pnina Fishman Ph.D.
Founder, Chief Scientific Officer & Executive Chairman
Dr. Vibeke S. Strand FACP, FACR, FACR (USA), M.D.
Senior Clinical Advisor
Mr. Motti Farbstein
Chief Executive Officer & Chief Operating and Financial Officer
Dr. Ilan Cohn Ph.D.
Co-Founder & Director

How CANF did perform over past 52-week?

CANF's closing price is 17.83% higher than its 52-week low of $1.29 where as its distance from 52-week high of $4.69 is -67.59%.

How many employees does CANF have?

Number of CANF employees currently stands at 8.

Link for CANF official website?

Official Website of CANF is: https://www.canfite.com

How do I contact CANF?

CANF could be contacted at phone 972 392 41114 and can also be accessed through its website. CANF operates from 10 Bareket Street, Petah Tikva, 4951778, Israel.

How many shares of CANF are traded daily?

CANF stock volume for the day was 63.65K shares. The average number of CANF shares traded daily for last 3 months was 191.69K.

What is the market cap of CANF currently?

The market value of CANF currently stands at $9.27M with its latest stock price at $1.52 and 6.1M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

CANF Stock Price Chart

Stock Price Today

Stock Snapshot

1.4

Prev. Close

1.41

Open

9.27M

Market Cap

6.1M

Number of Shares

1.415

Day Low

1.52

Day High

-0.58

P/E Ratio

27,304.3%

Free Float in %

-2.6

EPS (TTM)

1.38

Book Value

0.02

Cash Flow per Share

63.65K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	1.41	1.52	1.41	1.52	63.6K
Apr 01, 2025	1.46	1.50	1.38	1.40	124.84K
Mar 31, 2025	1.45	1.49	1.45	1.48	41.78K
Mar 28, 2025	1.50	1.56	1.44	1.48	96.45K
Mar 27, 2025	1.51	1.54	1.51	1.54	51.97K
Mar 26, 2025	1.53	1.59	1.51	1.52	81.04K
Mar 25, 2025	1.58	1.63	1.53	1.57	92.02K
Mar 24, 2025	1.74	1.74	1.55	1.62	418.59K
Mar 21, 2025	1.53	1.66	1.51	1.60	186.3K
Mar 20, 2025	1.61	1.75	1.50	1.51	374.47K
Mar 19, 2025	2.10	2.33	1.59	1.63	1.74M
Mar 18, 2025	1.90	2.21	1.67	2.02	3.5M
Mar 17, 2025	1.65	1.76	1.60	1.65	52.62K
Mar 14, 2025	1.56	1.65	1.54	1.63	35.8K
Mar 13, 2025	1.53	1.57	1.52	1.56	14.44K
Mar 12, 2025	1.51	1.58	1.51	1.55	28.7K
Mar 11, 2025	1.53	1.59	1.46	1.55	21.84K
Mar 10, 2025	1.59	1.61	1.45	1.53	53.04K
Mar 07, 2025	1.56	1.76	1.54	1.58	32.7K
Mar 06, 2025	1.62	1.63	1.52	1.60	34.06K

Contact Details

Petah Tikva, 4951778

Israel

Website: https://www.canfite.comContact: 972 392 41114

About Company

Frequently Asked Questions

What is the current Can-Fite BioPharma Ltd. (CANF) stock price?

CANF's industry and sector of operation?

Who are the executives of CANF?

How CANF did perform over past 52-week?

CANF's closing price is 17.83% higher than its 52-week low of $1.29 where as its distance from 52-week high of $4.69 is -67.59%.

How many employees does CANF have?

Number of CANF employees currently stands at 8.

Link for CANF official website?

Official Website of CANF is: https://www.canfite.com

How do I contact CANF?

CANF could be contacted at phone 972 392 41114 and can also be accessed through its website. CANF operates from 10 Bareket Street, Petah Tikva, 4951778, Israel.

How many shares of CANF are traded daily?

CANF stock volume for the day was 63.65K shares. The average number of CANF shares traded daily for last 3 months was 191.69K.

What is the market cap of CANF currently?

The market value of CANF currently stands at $9.27M with its latest stock price at $1.52 and 6.1M of its shares outstanding.

Employees	8
Beta	0.26
Sales or Revenue	$743.00K
5Y Sales Change%	-0.994%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	8
Beta	0.26
Sales or Revenue	$743.00K
5Y Sales Change%	-0.994%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

CANF Company Profile and Key Details

Can-Fite BioPharma Ltd.

CANF Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

CANF Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions